Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres.

IF 2 4区医学 Q3 ONCOLOGY Oncology Research and Treatment Pub Date : 2023-01-01 DOI:10.1159/000530425

Johannes Rückher, Ellen Grießhammer, Thomas Langer, Gregor Wenzel, Martin Utzig, Peter Hohenberger, Lars H Lindner, Jens Jakob, Simone Wesselmann

{"title":"Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres.","authors":"Johannes Rückher, Ellen Grießhammer, Thomas Langer, Gregor Wenzel, Martin Utzig, Peter Hohenberger, Lars H Lindner, Jens Jakob, Simone Wesselmann","doi":"10.1159/000530425","DOIUrl":null,"url":null,"abstract":"Introduction: Soft tissue sarcomas (STSs) are rare diseases. A high level of standardization and centralization was lacking in Germany until 2018.Methods: By developing an evidence-based guideline and a certification system for sarcoma centres, foundations for structured, guideline-based, and centralized sarcoma care were defined. First results of the certified sarcoma centres are presented.Results: The first 3 years of data collection show good results for case volume, presentation rates in pretherapeutic and postoperative tumour boards, psycho-oncological counselling, and study rates. However, other indicators (e.g., preoperative or postoperative radiotherapy for operated high-risk STS without GIST, counselling rates social services) still have potential for improvement. Based on these results, the set of indicators could be further improved.Conclusions: A sarcoma-specific quality assurance scheme that includes guideline-derived quality indicators was developed. In future, a broader database will allow further insights into sarcoma care in Germany.","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":"46 6","pages":"236-245"},"PeriodicalIF":2.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000530425","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 1

Abstract

Introduction: Soft tissue sarcomas (STSs) are rare diseases. A high level of standardization and centralization was lacking in Germany until 2018.

Methods: By developing an evidence-based guideline and a certification system for sarcoma centres, foundations for structured, guideline-based, and centralized sarcoma care were defined. First results of the certified sarcoma centres are presented.

Results: The first 3 years of data collection show good results for case volume, presentation rates in pretherapeutic and postoperative tumour boards, psycho-oncological counselling, and study rates. However, other indicators (e.g., preoperative or postoperative radiotherapy for operated high-risk STS without GIST, counselling rates social services) still have potential for improvement. Based on these results, the set of indicators could be further improved.

Conclusions: A sarcoma-specific quality assurance scheme that includes guideline-derived quality indicators was developed. In future, a broader database will allow further insights into sarcoma care in Germany.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

德国软组织肉瘤的质量测量:经认证的肉瘤中心的初步结果。

简介:软组织肉瘤是一种罕见的疾病。直到2018年，德国还缺乏高度的标准化和集中化。方法:通过为肉瘤中心制定循证指南和认证系统，确定结构化、基于指南和集中式肉瘤护理的基础。介绍经认证的肉瘤中心的初步结果。结果:前3年的数据收集显示，在病例数量、治疗前和术后肿瘤委员会的出现率、肿瘤心理咨询和学习率方面取得了良好的结果。然而，其他指标(例如，手术高风险STS术前或术后放射治疗，咨询率和社会服务)仍有改善的潜力。根据这些结果，这套指标可以进一步改进。结论:开发了一种肉瘤特异性质量保证方案，包括指南衍生的质量指标。未来，一个更广泛的数据库将有助于进一步了解德国的肉瘤治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Oncology Research and Treatment ONCOLOGY-

CiteScore

3.20

自引率

0.00%

发文量

期刊介绍： With the first issue in 2014, the journal ''Onkologie'' has changed its title to ''Oncology Research and Treatment''. By this change, publisher and editor set the scene for the further development of this interdisciplinary journal. The English title makes it clear that the articles are published in English – a logical step for the journal, which is listed in all relevant international databases. For excellent manuscripts, a ''Fast Track'' was introduced: The review is carried out within 2 weeks; after acceptance the papers are published online within 14 days and immediately released as ''Editor’s Choice'' to provide the authors with maximum visibility of their results. Interesting case reports are published in the section ''Novel Insights from Clinical Practice'' which clearly highlights the scientific advances which the report presents.